Assessing and managing depression in the terminally ill patient

被引:244
|
作者
Block, SD
机构
[1] Dana-Farber Cancer Institute, Boston, MA 02115
[2] Ctr. for Ethics and Professionalism, American College of Physicians, Amer. Society of Internal Medicine, Philadelphia, PA 19106
关键词
D O I
10.7326/0003-4819-132-3-200002010-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psychological distress often causes suffering in terminally ill patients and their families and poses challenges in diagnosis and treatment. Increased attention to diagnosis and treatment of depression can improve the coping mechanisms of patients and families. This paper reviews the clinical characteristics of normal grief and clinical depression and explains strategies for differential diagnosis. Although some literature discusses the psychological issues facing elderly patients and terminally ill patients with cancer, less is known about patients with end-stage pulmonary, cardiac, renal, and neurologic disease. Data on the effectiveness of interventions in terminally ill patients are lacking. Treatment recommendations in this paper represent extrapolations from existing literature and expert opinion. Diagnosing and treating depression in terminally ill patients involve unique challenges. Evidence of hopelessness, helplessness, worthlessness, guilt, and suicidal ideation are better indicators of depression in this context than neurovegetative symptoms. Although terminally ill patients often have suicidal thoughts, they are usually fleeting. Sustained suicidal ideation should prompt a comprehensive evaluation. Clinicians should have a low threshold for treating depression in terminally ill patients. Psychostimulants, because of their rapid onset of action, are useful agents and are generally well tolerated. Selective serotonin reuptake inhibitors and tricyclic antidepressants may also be used. Psychological interventions- including eliciting concerns and conveying the potential for connection, meaning, reconciliation, and closure in the dying process-can also facilitate coping.
引用
收藏
页码:209 / 218
页数:10
相关论文
共 50 条
  • [21] EPIDURAL MORPHINE IN A TERMINALLY ILL PATIENT
    MCCOY, DD
    MILLER, MG
    ANESTHESIOLOGY, 1982, 57 (05) : 427 - 427
  • [22] The right to information for the terminally ill patient
    Osuna, E
    Perez-Carceles, MD
    Esteban, MA
    Luna, A
    JOURNAL OF MEDICAL ETHICS, 1998, 24 (02) : 106 - 109
  • [23] COGNITIVE FAILURE IN A TERMINALLY ILL PATIENT
    FAINSINGER, R
    YOUNG, C
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1991, 6 (08) : 492 - 494
  • [24] Palliative Sedation for the Terminally Ill Patient
    Garetto, Ferdinando
    Cancelli, Ferdinando
    Rossi, Romina
    Maltoni, Marco
    CNS DRUGS, 2018, 32 (10) : 951 - 961
  • [25] Palliative Sedation for the Terminally Ill Patient
    Ferdinando Garetto
    Ferdinando Cancelli
    Romina Rossi
    Marco Maltoni
    CNS Drugs, 2018, 32 : 951 - 961
  • [26] MORPHINE AND DIAMORPHINE IN THE TERMINALLY ILL PATIENT
    TWYCROSS, RG
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1982, 26 : 128 - 134
  • [27] Artificial hydration in the terminally ill patient
    Boland, Elaine
    Johnson, Miriam
    Boland, Jason
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (07) : 397 - 401
  • [28] The terminally Ill patient: The law in Israel
    Perry, S.
    Steinberg, A.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S366 - S366
  • [29] USE OF CHLORPROMAZINE IN TERMINALLY ILL PATIENT
    LANDIS, JB
    JOURNAL OF THANATOLOGY, 1972, 2 (1-2): : 615 - 622
  • [30] Management of bleeding in the terminally ill patient
    Prommer, E
    HEMATOLOGY, 2005, 10 (03) : 167 - 175